Skip to main content
OpenTrials

Clinical trial condition

Relapsing Multiple Sclerosis

Explore clinical trials studying Relapsing Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

69 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Relapsing Multiple Sclerosis trial results

Recruiting

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

NCT05877963

Conditions
Relapsing Multiple Sclerosis
Locations
  • TG Therapeutics Investigational Trial Site Birmingham, Alabama, United States
  • TG Therapeutics Investigational Trial Site Cullman, Alabama, United States
  • TG Therapeutics Investigational Trial Site Orange, California, United States
  • TG Investigational Site Fort Collins, Colorado, United States
View all 51 locations
View Trial Details
Recruiting

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

NCT04047628

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +13 more
Locations
  • Stanford Multiple Sclerosis Center Palo Alto, California, United States
  • Rocky Mountain Multiple Sclerosis Center, University of Colorado School of Medicine Aurora, Colorado, United States
  • Northwestern University Evanston, Illinois, United States
  • University of Massachusetts Memorial Medical Center Worcester, Massachusetts, United States
View all 23 locations
View Trial Details
Recruiting

A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)

NCT07161258

Conditions
Relapsing Multiple Sclerosis
Locations
  • INECO Neurociencias Orono Rosario, Santa Fe Province, Argentina
  • Sanatorio del Sur S.A. San Miguel de Tucumán, Argentina
  • L2IP ?Instituto de Pesquisas Clínicas Ltda. Brasília, Federal District, Brazil
  • Instituto de Neurologia de Curitiba - Hospital Ecoville Curitiba, Paraná, Brazil
View all 17 locations
View Trial Details
Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

NCT06433752

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • TG Therapeutics Investigational Trial Site Birmingham, Alabama, United States
  • TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
  • TG Therapeutics Investigational Trial Site Mobile, Alabama, United States
  • TG Therapeutics Investigational Trial Site Gilbert, Arizona, United States
View all 109 locations
View Trial Details
Recruiting

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

NCT06846281

Conditions
Relapsing Multiple Sclerosis
Locations
  • Perseverance Research Center Scottsdale, Arizona, United States
  • University of California Irvine Irvine, California, United States
  • Medstar Washington Hospital Center Washington D.C., District of Columbia, United States
  • Neurology of Central FL Res Ctr Altamonte Springs, Florida, United States
View all 129 locations
View Trial Details
Recruiting

A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk

NCT06143514

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • PROVIDE Virtual Research Coordination Center San Francisco, California, United States
  • PROVIDE Virtual Research Coordination Center Smyrna, Georgia, United States
  • TG Therapeutics Investigational Trial Site Boston, Massachusetts, United States
  • PROVIDE Virtual Research Coordination Center Wilmington, North Carolina, United States
View Trial Details

Related conditions